61 results
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
29 Mar 24
Report of Foreign Private Issuer
4:30pm
to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud, and whether effective … procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond
6-K
EX-99.1
b79q2z 818
31 Mar 23
Report of Foreign Private Issuer
4:30pm
424B5
djhlhgoie
30 Dec 22
Prospectus supplement for primary offering
4:01pm
F-3
41hqqpavm84cg i3
29 Apr 22
Shelf registration (foreign)
8:14am
424B5
biodjqzyxjno85f
10 Feb 21
Prospectus supplement for primary offering
5:22pm
424B5
4bsz5018bxqxl8cg
9 Feb 21
Prospectus supplement for primary offering
4:56pm
424B5
mscy9
22 Oct 20
Prospectus supplement for primary offering
8:45am